GNPAT/USP30稳定了DRP1蛋白质,促进了COPD进展中的线粒体裂变和功能损伤
Xin-Gui Cheng1, Yun-Chan Liu2, Fei Chen3
1Pulmonary and Critical Care Medicine, Hainan Affiliated Hospital of Hainan Medical University, Haikou, China.
The Kaohsiung journal of medical sciences
|July 25, 2025
概括
在慢性阻塞性肺病 (COPD) 中,甘油酸盐O-转移酶 (GNPAT) 通过全方位素特异性蛋白酶30 (USP30) 稳定动胺相关蛋白1 (DRP1). 这种机制促进了线粒体分裂和亡,为COPD提供了潜在的治疗点.
科学领域:
- 细胞生物学 细胞生物学
- 肺部医学 肺部医学
- 生物化学 生物化学
背景情况:
- 甘酸O-转移酶 (GNPAT) 在慢性阻塞性肺病 (COPD) 中起着已知的作用,但其精确的机制尚未完全理解.
- 进一步调查GNPAT在COPD发病过程中的作用对于确定治疗点至关重要.
研究的目的:
- 阐明GNPAT调节COPD的分子机制.
- 在COPD模型中调查GNPAT,USP30和DRP1在线粒体功能障碍和亡中的作用.
主要方法:
- 香烟烟雾引起的COPD小鼠模型和暴露于香烟烟雾提取物 (CSE) 的A549细胞培养物.
- 组织学分析 (H&E,免疫组织化学),基于细胞的测定 (活力,亡,LDH,ATP,ROS),分子生物学技术 (qPCR,西式斑点,共免疫沉) 和电子显微镜.
- 使用等离子体转染和药理抑制对基因表达的操纵.
主要成果:
- 在COPD模型中,GNPAT和DRP1被调高了.
- 暴露于CSE诱导了线粒体裂变,功能障碍和亡,这些影响被裂变诱导剂加剧.
- 通过USP30,GNPAT稳定了DRP1蛋白,导致线粒体分裂,功能障碍和亡的增加;抑制GNPAT/USP30扭转了这些影响.
结论:
- GNPAT招募USP30来稳定DRP1,促进线粒体裂变和功能障碍,这有助于COPD中的亡.
- GNPAT/USP30/DRP1轴代表了COPD病变发生的新途径.
- 这一途径表明GNPAT是COPD的潜在治疗生物标志物.
相关概念视频
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
01:20COPD: Pathogenesis and Clinical Features
528
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
528
01:26COPD: Management Using Bronchodilators and Corticosteroids
314
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
314
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
01:22Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K